{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,10,27]],"date-time":"2026-10-27T06:43:41Z","timestamp":1793083421275,"version":"4.5.0"},"reference-count":75,"publisher":"Springer Science and Business Media LLC","issue":"1","license":[{"start":{"date-parts":[[2020,1,23]],"date-time":"2020-01-23T00:00:00Z","timestamp":1579737600000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/creativecommons.org\/licenses\/by\/4.0"},{"start":{"date-parts":[[2020,1,23]],"date-time":"2020-01-23T00:00:00Z","timestamp":1579737600000},"content-version":"vor","delay-in-days":0,"URL":"https:\/\/creativecommons.org\/licenses\/by\/4.0"}],"funder":[{"name":"KRIBB Research Initiative Program"}],"content-domain":{"domain":["link.springer.com"],"crossmark-restriction":false},"short-container-title":["Sci Rep"],"abstract":"<jats:title>Abstract<\/jats:title><jats:p>Chronic lymphocytic leukaemia (CLL) exhibits differences between Asians and Caucasians in terms of incidence rate, age at onset, immunophenotype, and genetic profile. We performed genome-wide methylation profiling of CLL in an Asian cohort for the first time. Eight Korean patients without somatic immunoglobulin heavy chain gene hypermutations underwent methyl-CpG-binding domain sequencing (MBD-seq), as did five control subjects. Gene Ontology, pathway analysis, and network-based prioritization of differentially methylated genes were also performed. More regions were hypomethylated (2,062 windows) than were hypermethylated (777 windows). Promoters contained the highest proportion of differentially methylated regions (0.08%), while distal intergenic and intron regions contained the largest number of differentially methylated regions. Protein-coding genes were the most abundant, followed by long noncoding and short noncoding genes. The most significantly over-represented signalling pathways in the differentially methylated gene list included immune\/cancer-related pathways and B-cell receptor signalling. Among the top 10 hub genes identified via network-based prioritization, four (<jats:italic>UBC<\/jats:italic>, <jats:italic>GRB2<\/jats:italic>, <jats:italic>CREBBP<\/jats:italic>, and <jats:italic>GAB2<\/jats:italic>) had no known relevance to CLL, while the other six (<jats:italic>STAT3<\/jats:italic>, <jats:italic>PTPN6<\/jats:italic>, <jats:italic>SYK<\/jats:italic>, <jats:italic>STAT5B<\/jats:italic>, <jats:italic>XPO1<\/jats:italic>, and <jats:italic>ABL1<\/jats:italic>) have previously been linked to CLL in Caucasians. As such, our analysis identified four novel candidate genes of potential significance to Asian patients with CLL.<\/jats:p>","DOI":"10.1038\/s41598-020-57919-6","type":"journal-article","created":{"date-parts":[[2020,1,23]],"date-time":"2020-01-23T11:02:58Z","timestamp":1579777378000},"update-policy":"https:\/\/doi.org\/10.1007\/springer_crossmark_policy","source":"Crossref","is-referenced-by-count":7,"title":["Novel genes exhibiting DNA methylation alterations in Korean patients with chronic lymphocytic leukaemia: a methyl-CpG-binding domain sequencing study"],"prefix":"10.1038","volume":"10","author":[{"given":"Miyoung","family":"Kim","sequence":"first","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Eunyup","family":"Lee","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Dae Young","family":"Zang","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Hyo Jung","family":"Kim","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Ho Young","family":"Kim","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Boram","family":"Han","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Han-Sung","family":"Kim","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Hee Jung","family":"Kang","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Seungwoo","family":"Hwang","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Young Kyung","family":"Lee","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"297","published-online":{"date-parts":[[2020,1,23]]},"reference":[{"key":"57919_CR1","unstructured":"Swerdlow, S. H. et al. Chronic lymphocytic leukaemia\/small lymphocytic lymphoma. In WHO Classification of Tumours of Haematopoietic and Lymphoid Tissues (eds. Campo, E. et al.) 216\u2013219 (IARC, 2017)."},{"key":"57919_CR2","doi-asserted-by":"publisher","first-page":"e0167641","DOI":"10.1371\/journal.pone.0167641","volume":"11","author":"JA Kim","year":"2016","unstructured":"Kim, J. A. et al. Genomic Profile of Chronic Lymphocytic Leukemia in Korea Identified by Targeted Sequencing. PLoS One. 11, e0167641 (2016).","journal-title":"PLoS One."},{"key":"57919_CR3","doi-asserted-by":"publisher","first-page":"403","DOI":"10.1007\/s12185-013-1286-z","volume":"97","author":"MA Jang","year":"2016","unstructured":"Jang, M. A. et al. Chronic lymphocytic leukemia in Korean patients: frequent atypical immunophenotype and relatively aggressive clinical behavior. Int. J. Hematol. 97, 403\u20138 (2016).","journal-title":"Int. J. Hematol."},{"key":"57919_CR4","doi-asserted-by":"crossref","first-page":"5426","DOI":"10.18632\/oncotarget.3101","volume":"6","author":"Y Xia","year":"2015","unstructured":"Xia, Y. et al. Frequencies of SF3B1, NOTCH1, MYD88, BIRC3 and IGHV mutations and TP53 disruptions in Chinese with chronic lymphocytic leukemia: disparities with Europeans. Oncotarget. 6, 5426\u201334 (2015).","journal-title":"Oncotarget."},{"key":"57919_CR5","doi-asserted-by":"publisher","first-page":"862","DOI":"10.1182\/blood-2010-05-284638","volume":"117","author":"SS Chen","year":"2011","unstructured":"Chen, S. S. et al. Silencing of the inhibitor of DNA binding protein 4 (ID4) contributes to the pathogenesis of mouse and human CLL. Blood. 117, 862\u201371 (2011).","journal-title":"Blood."},{"key":"57919_CR6","first-page":"1078","volume":"90","author":"M Corcoran","year":"2005","unstructured":"Corcoran, M. et al. ZAP-70 methylation status is associated with ZAP-70 expression status in chronic lymphocytic leukemia. Haematologica. 90, 1078\u201388 (2005).","journal-title":"Haematologica."},{"key":"57919_CR7","doi-asserted-by":"publisher","first-page":"879","DOI":"10.1016\/j.cell.2007.03.043","volume":"129","author":"A Raval","year":"2007","unstructured":"Raval, A. et al. Downregulation of death-associated protein kinase 1 (DAPK1) in chronic lymphocytic leukemia. Cell. 129, 879\u201390 (2007).","journal-title":"Cell."},{"key":"57919_CR8","doi-asserted-by":"publisher","first-page":"419","DOI":"10.1080\/10428190902756594","volume":"50","author":"B Seeliger","year":"2009","unstructured":"Seeliger, B., Wilop, S., Osieka, R., Galm, O. & Jost, E. CpG island methylation patterns in chronic lymphocytic leukemia. Leuk. Lymphoma. 50, 419\u201326 (2009).","journal-title":"Leuk. Lymphoma."},{"key":"57919_CR9","doi-asserted-by":"publisher","first-page":"296","DOI":"10.1182\/blood-2009-07-232868","volume":"115","author":"M Kanduri","year":"2010","unstructured":"Kanduri, M. et al. Differential genome-wide array-based methylation profiles in prognostic subsets of chronic lymphocytic leukemia. Blood. 115, 296\u2013305 (2010).","journal-title":"Blood."},{"key":"57919_CR10","doi-asserted-by":"publisher","first-page":"150","DOI":"10.1038\/leu.2012.245","volume":"27","author":"N Cahill","year":"2013","unstructured":"Cahill, N. et al. 450K-array analysis of chronic lymphocytic leukemia cells reveals global DNA methylation to be relatively stable over time and similar in resting and proliferative compartments. Leukemia. 27, 150\u20138 (2013).","journal-title":"Leukemia."},{"key":"57919_CR11","doi-asserted-by":"publisher","first-page":"1236","DOI":"10.1038\/ng.2443","volume":"44","author":"M Kulis","year":"2012","unstructured":"Kulis, M. et al. Epigenomic analysis detects widespread gene-body DNA hypomethylation in chronic lymphocytic leukemia. Nat. Genet. 44, 1236\u201342 (2012).","journal-title":"Nat. Genet."},{"key":"57919_CR12","doi-asserted-by":"publisher","first-page":"813","DOI":"10.1016\/j.ccell.2014.10.012","volume":"26","author":"DA Landau","year":"2014","unstructured":"Landau, D. A. et al. Locally disordered methylation forms the basis of intratumor methylome variation in chronic lymphocytic leukemia. Cancer Cell. 26, 813\u2013825 (2014).","journal-title":"Cancer Cell."},{"key":"57919_CR13","doi-asserted-by":"publisher","first-page":"391","DOI":"10.1093\/nar\/gkp992","volume":"38","author":"D Serre","year":"2010","unstructured":"Serre, D., Lee, B. H. & Ting, A. H. MBD-isolated Genome Sequencing provides a high-throughput and comprehensive survey of DNA methylation in the human genome. Nucleic Acids Res. 38, 391\u20139 (2010).","journal-title":"Nucleic Acids Res."},{"key":"57919_CR14","doi-asserted-by":"publisher","first-page":"605","DOI":"10.2217\/epi.12.59","volume":"4","author":"KA Aberg","year":"2012","unstructured":"Aberg, K. A. et al. MBD-seq as a cost-effective approach for methylome-wide association studies: demonstration in 1500 case\u2013control samples. Epigenomics. 4, 605\u201321 (2012).","journal-title":"Epigenomics."},{"key":"57919_CR15","doi-asserted-by":"publisher","first-page":"1097","DOI":"10.1038\/nbt.1682","volume":"28","author":"RA Harris","year":"2010","unstructured":"Harris, R. A. et al. Comparison of sequencing-based methods to profile DNA methylation and identification of monoallelic epigenetic modifications. Nat. Biotechnol. 28, 1097\u2013105 (2010).","journal-title":"Nat. Biotechnol."},{"key":"57919_CR16","doi-asserted-by":"publisher","DOI":"10.1186\/s13148-016-0274-6","volume":"8","author":"S Subhash","year":"2016","unstructured":"Subhash, S., Andersson, P. O., Kosalai, S. T., Kanduri, C. & Kanduri, M. Global DNA methylation profiling reveals new insights into epigenetically deregulated protein coding and long noncoding RNAs in CLL. Clin. Epigenetics. 8, 106 (2016).","journal-title":"Clin. Epigenetics."},{"key":"57919_CR17","doi-asserted-by":"publisher","first-page":"138","DOI":"10.4161\/epi.23439","volume":"8","author":"N Cahill","year":"2013","unstructured":"Cahill, N. & Rosenquist, R. Uncovering the DNA methylome in chronic lymphocytic leukemia. Epigenetics. 8, 138\u201348 (2013).","journal-title":"Epigenetics."},{"key":"57919_CR18","doi-asserted-by":"publisher","first-page":"567","DOI":"10.4161\/epi.20237","volume":"7","author":"L Pei","year":"2012","unstructured":"Pei, L. et al. Genome-wide DNA methylation analysis reveals novel epigenetic changes in chronic lymphocytic leukemia. Epigenetics. 7, 567\u201378 (2012).","journal-title":"Epigenetics."},{"key":"57919_CR19","doi-asserted-by":"publisher","first-page":"746","DOI":"10.1038\/ng.3291","volume":"47","author":"M Kulis","year":"2015","unstructured":"Kulis, M. et al. Whole-genome fingerprint of the DNA methylome during human B cell differentiation. Nat. Genet. 47, 746\u201356 (2015).","journal-title":"Nat. Genet."},{"key":"57919_CR20","doi-asserted-by":"publisher","first-page":"5400","DOI":"10.1038\/sj.onc.1205651","volume":"21","author":"M Ehrlich","year":"2002","unstructured":"Ehrlich, M. DNA methylation in cancer: too much, but also too little. Oncogene. 21, 5400\u20135413 (2002).","journal-title":"Oncogene."},{"key":"57919_CR21","doi-asserted-by":"crossref","first-page":"1028","DOI":"10.1158\/1078-0432.1028.11.3","volume":"11","author":"T Ogishima","year":"2005","unstructured":"Ogishima, T. et al. Increased heparanase expression is caused by promoter hypomethylation and upregulation of transcriptional factor early growth response-1 in human prostate cancer. Clin. Cancer Res. 11, 1028\u20131036 (2005).","journal-title":"Clin. Cancer Res."},{"key":"57919_CR22","doi-asserted-by":"publisher","first-page":"489","DOI":"10.1126\/science.1083558","volume":"300","author":"F Gaudet","year":"2003","unstructured":"Gaudet, F. et al. Induction of tumors in mice by genomic hypomethylation. Science. 300, 489\u2013492 (2003).","journal-title":"Science."},{"key":"57919_CR23","doi-asserted-by":"publisher","first-page":"34","DOI":"10.1016\/S0165-4608(98)00143-5","volume":"109","author":"G Qu","year":"1999","unstructured":"Qu, G., Grundy, P. E., Narayan, A. & Ehrlich, M. Frequent hypomethylation in Wilms tumors of pericentromeric DNA in chromosomes 1 and 16. Cancer Genet. Cytogenet. 109, 34\u201339 (1999).","journal-title":"Cancer Genet. Cytogenet."},{"key":"57919_CR24","doi-asserted-by":"publisher","DOI":"10.1186\/1471-2164-11-48","volume":"11","author":"YA Medvedeva","year":"2010","unstructured":"Medvedeva, Y. A. et al. Intergenic, gene terminal, and intragenic CpG islands in the human genome. BMC Genomics. 11, 48 (2010).","journal-title":"BMC Genomics."},{"key":"57919_CR25","doi-asserted-by":"publisher","first-page":"168","DOI":"10.1016\/S0168-9525(99)01971-X","volume":"16","author":"SB Baylin","year":"2000","unstructured":"Baylin, S. B. & Herman, J. G. DNA hypermethylation in tumorigenesis: epigenetics joins genetics. Trends. Genet. 16, 168\u201374 (2000).","journal-title":"Trends. Genet."},{"key":"57919_CR26","doi-asserted-by":"publisher","first-page":"R50","DOI":"10.1093\/hmg\/ddm018","volume":"16","author":"M Esteller","year":"2007","unstructured":"Esteller, M. Epigenetic gene silencing in cancer: the DNA hypermethylome. Hum. Mol. Genet. 16, R50\u20139 (2007).","journal-title":"Hum. Mol. Genet."},{"key":"57919_CR27","doi-asserted-by":"publisher","first-page":"1001","DOI":"10.4161\/cc.6.9.4209","volume":"6","author":"B Weber","year":"2007","unstructured":"Weber, B., Stresemann, C., Brueckner, B. & Lyko, F. Methylation of human microRNA genes in normal and neoplastic cells. Cell Cycle. 6, 1001\u20135 (2007).","journal-title":"Cell Cycle."},{"key":"57919_CR28","doi-asserted-by":"publisher","first-page":"5003","DOI":"10.1038\/onc.2014.456","volume":"34","author":"H Ling","year":"2015","unstructured":"Ling, H. et al. Junk DNA and the long non-coding RNA twist in cancer genetics. Oncogene. 34, 5003\u20135011 (2015).","journal-title":"Oncogene."},{"key":"57919_CR29","doi-asserted-by":"publisher","first-page":"1097","DOI":"10.1016\/j.bbagrm.2014.08.012","volume":"1839","author":"G Yang","year":"2014","unstructured":"Yang, G., Lu, X. & Yuan, L. LncRNA: a link between RNA and cancer. Biochim. Biophys. Acta. 1839, 1097\u20131109 (2014).","journal-title":"Biochim. Biophys. Acta."},{"key":"57919_CR30","doi-asserted-by":"publisher","first-page":"60605","DOI":"10.18632\/oncotarget.17303","volume":"8","author":"L Nobili","year":"2017","unstructured":"Nobili, L., Ronchetti, D., Taiana, E. & Neri, A. Long non-coding RNAs in B-cell malignancies: a comprehensive overview. Oncotarget. 8, 60605\u201360623 (2017).","journal-title":"Oncotarget."},{"key":"57919_CR31","doi-asserted-by":"publisher","first-page":"54174","DOI":"10.18632\/oncotarget.11099","volume":"7","author":"A Sattari","year":"2016","unstructured":"Sattari, A. et al. Upregulation of long noncoding RNA MIAT in aggressive form of chronic lymphocytic leukemias. Oncotarget. 7, 54174\u201354182 (2016).","journal-title":"Oncotarget."},{"key":"57919_CR32","first-page":"134","volume":"2","author":"V Balatti","year":"2016","unstructured":"Balatti, V., Acunzo, M., Pekarky, Y. & Croce, C. M. Novel mechanisms of regulation of miRNAs in CLL. Trends. Cancer. 2, 134\u2013143 (2016).","journal-title":"Cancer."},{"key":"57919_CR33","doi-asserted-by":"publisher","first-page":"E2911","DOI":"10.1073\/pnas.1702564114","volume":"114","author":"G Fabbri","year":"2017","unstructured":"Fabbri, G. et al. Common nonmutational NOTCH1 activation in chronic lymphocytic leukemia. Proc. Natl. Acad. Sci. USA 114, E2911\u2013E2919 (2017).","journal-title":"Proc. Natl. Acad. Sci. USA"},{"key":"57919_CR34","doi-asserted-by":"publisher","first-page":"576","DOI":"10.3324\/haematol.2018.196931","volume":"104","author":"N Gim\u00e9nez","year":"2019","unstructured":"Gim\u00e9nez, N. et al. Mutations in the RAS-BRAF-MAPK-ERK pathway define a specific subgroup of patients with adverse clinical features and provide new therapeutic options in chronic lymphocytic leukemia. Haematologica. 104, 576\u2013586 (2019).","journal-title":"Haematologica."},{"key":"57919_CR35","doi-asserted-by":"publisher","first-page":"2336","DOI":"10.1182\/blood-2014-08-595934","volume":"125","author":"J Sharman","year":"2015","unstructured":"Sharman, J. et al. An open-label phase 2 trial of entospletinib (GS-9973), a selective spleen tyrosine kinase inhibitor, in chronic lymphocytic leukemia. Blood. 125, 2336\u201343 (2015).","journal-title":"Blood."},{"key":"57919_CR36","doi-asserted-by":"publisher","first-page":"322","DOI":"10.1002\/ijc.31057","volume":"142","author":"C Wolf","year":"2018","unstructured":"Wolf, C. et al. NFATC1 activation by DNA hypomethylation in chronic lymphocytic leukemia correlates with clinical staging and can be inhibited by ibrutinib. Int. J. Cancer. 142, 322\u2013333 (2018).","journal-title":"Int. J. Cancer."},{"key":"57919_CR37","doi-asserted-by":"publisher","first-page":"e0137132","DOI":"10.1371\/journal.pone.0137132","volume":"10","author":"S Yepes","year":"2015","unstructured":"Yepes, S., Torres, M. M. & Andrade, R. E. Clustering of Expression Data in Chronic Lymphocytic Leukemia Reveals New Molecular Subdivisions. PLoS One. 10, e0137132 (2015).","journal-title":"PLoS One."},{"key":"57919_CR38","doi-asserted-by":"publisher","DOI":"10.1038\/srep44997","volume":"7","author":"S Bhalla","year":"2017","unstructured":"Bhalla, S. et al. Gene expression-based biomarkers for discriminating early and late stage of clear cell renal cancer. Sci. Rep. 7, 44997 (2017).","journal-title":"Sci. Rep."},{"key":"57919_CR39","doi-asserted-by":"publisher","DOI":"10.1038\/srep09476","volume":"5","author":"Y Tang","year":"2015","unstructured":"Tang, Y. et al. Downregulation of ubiquitin inhibits the proliferation and radioresistance of non-small cell lung cancer cells in vitro and in vivo. Sci. Rep. 5, 9476 (2015).","journal-title":"Sci. Rep."},{"key":"57919_CR40","doi-asserted-by":"publisher","first-page":"1084","DOI":"10.2174\/0929866525666171123213148","volume":"24","author":"M Ijaz","year":"2018","unstructured":"Ijaz, M. et al. The Role of Grb2 in Cancer and Peptides as Grb2 Antagonists. Protein. Pept. Lett. 24, 1084\u20131095 (2018).","journal-title":"Protein. Pept. Lett."},{"key":"57919_CR41","doi-asserted-by":"publisher","first-page":"736","DOI":"10.3324\/haematol.2016.145177","volume":"102","author":"ZA Dixon","year":"2017","unstructured":"Dixon, Z. A. et al. CREBBP knockdown enhances RAS\/RAF\/MEK\/ERK signaling in Ras pathway mutated acute lymphoblastic leukemia but does not modulate chemotherapeutic response. Haematologica. 102, 736\u2013745 (2017).","journal-title":"Haematologica."},{"key":"57919_CR42","doi-asserted-by":"publisher","first-page":"150","DOI":"10.1111\/ejh.12897","volume":"99","author":"C Gao","year":"2017","unstructured":"Gao, C. et al. Low CREBBP expression is associated with adverse long-term outcomes in paediatric acute lymphoblastic leukaemia. Eur. J. Haematol. 99, 150\u2013159 (2017).","journal-title":"Eur. J. Haematol."},{"key":"57919_CR43","doi-asserted-by":"publisher","first-page":"9701","DOI":"10.1073\/pnas.1619555114","volume":"114","author":"H Hashwah","year":"2017","unstructured":"Hashwah, H. et al. Inactivation of CREBBP expands the germinal center B cell compartment, down-regulates MHCII expression and promotes DLBCL growth. Proc. Natl. Acad. Sci. USA 114, 9701\u20139706 (2017).","journal-title":"Proc. Natl. Acad. Sci. USA"},{"key":"57919_CR44","doi-asserted-by":"publisher","first-page":"1422","DOI":"10.1158\/2159-8290.CD-18-0385","volume":"8","author":"D Jia","year":"2018","unstructured":"Jia, D. et al. Crebbp Loss Drives Small Cell Lung Cancer and Increases Sensitivity to HDAC Inhibition. Cancer Discov. 8, 1422\u20131437 (2018).","journal-title":"Cancer Discov."},{"key":"57919_CR45","doi-asserted-by":"publisher","first-page":"235","DOI":"10.1038\/nature09727","volume":"471","author":"CG Mullighan","year":"2011","unstructured":"Mullighan, C. G. et al. CREBBP mutations in relapsed acute lymphoblastic leukaemia. Nature. 471, 235\u20139 (2011).","journal-title":"Nature."},{"key":"57919_CR46","doi-asserted-by":"publisher","first-page":"122","DOI":"10.1016\/S0962-8924(03)00002-3","volume":"13","author":"H Gu","year":"2003","unstructured":"Gu, H. & Neel, B. G. The \u201cGab\u201d in signal transduction. Trends Cell Biol. 13, 122\u201330 (2003).","journal-title":"Trends Cell Biol."},{"key":"57919_CR47","doi-asserted-by":"publisher","first-page":"1590","DOI":"10.1016\/S0140-6736(03)13308-9","volume":"361","author":"E Huang","year":"2003","unstructured":"Huang, E. et al. Gene expression predictors of breast cancer outcomes. Lancet. 361, 1590\u20131596 (2003).","journal-title":"Lancet."},{"key":"57919_CR48","doi-asserted-by":"publisher","first-page":"11763","DOI":"10.1007\/s13277-016-5019-9","volume":"37","author":"Y Chen","year":"2016","unstructured":"Chen, Y. et al. GAB2 promotes cell proliferation by activating the ERK signaling pathway in hepatocellular carcinoma. Tumour Biol. 37, 11763\u201311773 (2016).","journal-title":"Tumour Biol."},{"key":"57919_CR49","doi-asserted-by":"publisher","first-page":"778","DOI":"10.1016\/j.bbrc.2005.03.150","volume":"331","author":"AS Coutts","year":"2005","unstructured":"Coutts, A. S. & La Thangue, N. B. The p53 response: emerging levels of co-factor complexity. Biochem. Biophys. Res. Commun. 331, 778\u201385 (2005).","journal-title":"Biochem. Biophys. Res. Commun."},{"key":"57919_CR50","doi-asserted-by":"publisher","first-page":"274","DOI":"10.1016\/j.tig.2015.03.002","volume":"31","author":"G Lev Maor","year":"2015","unstructured":"Lev Maor, G., Yearim, A. & Ast, G. The alternative role of DNA methylation in splicing regulation. Trends Genet. 31, 274\u201380 (2015).","journal-title":"Trends Genet."},{"key":"57919_CR51","doi-asserted-by":"publisher","first-page":"253","DOI":"10.1038\/ng.3488","volume":"48","author":"CC Oakes","year":"2016","unstructured":"Oakes, C. C. et al. DNA methylation dynamics during B cell maturation underlie a continuum of disease phenotypes in chronic lymphocytic leukemia. Nat. Genet. 48, 253\u201364 (2016).","journal-title":"Nat. Genet."},{"key":"57919_CR52","doi-asserted-by":"publisher","first-page":"868","DOI":"10.1038\/s41591-018-0028-4","volume":"24","author":"R Beekman","year":"2018","unstructured":"Beekman, R. et al. The reference epigenome and regulatory chromatin landscape of chronic lymphocytic leukemia. Nat. Med. 24, 868\u2013880 (2018).","journal-title":"Nat. Med."},{"key":"57919_CR53","doi-asserted-by":"publisher","first-page":"1435","DOI":"10.4161\/epi.22901","volume":"7","author":"M Kanduri","year":"2012","unstructured":"Kanduri, M. et al. Distinct transcriptional control in major immunogenetic subsets of chronic lymphocytic leukemia exhibiting subset-biased global DNA methylation profiles. Epigenetics. 7, 1435\u201342 (2012).","journal-title":"Epigenetics."},{"key":"57919_CR54","doi-asserted-by":"publisher","first-page":"264","DOI":"10.1002\/gcc.22139","volume":"53","author":"D Ronchetti","year":"2014","unstructured":"Ronchetti, D. et al. Distinct patterns of global promoter methylation in early stage chronic lymphocytic leukemia. Genes Chromosomes Cancer. 53, 264\u201373 (2014).","journal-title":"Genes Chromosomes Cancer."},{"key":"57919_CR55","doi-asserted-by":"publisher","first-page":"537","DOI":"10.1038\/nature13268","volume":"510","author":"V Hovestadt","year":"2014","unstructured":"Hovestadt, V. et al. Decoding the regulatory landscape of medulloblastoma using DNA methylation sequencing. Nature. 510, 537\u201341 (2014).","journal-title":"Nature."},{"key":"57919_CR56","doi-asserted-by":"publisher","DOI":"10.1186\/gb-2013-14-3-r21","volume":"14","author":"D Aran","year":"2013","unstructured":"Aran, D., Sabato, S. & Hellman, A. DNA methylation of distal regulatory sites characterizes dysregulation of cancer genes. Genome Biol. 14, R21 (2013).","journal-title":"Genome Biol."},{"key":"57919_CR57","doi-asserted-by":"publisher","first-page":"45175","DOI":"10.1074\/jbc.M105384200","volume":"276","author":"S Yamasaki","year":"2001","unstructured":"Yamasaki, S. et al. Docking protein Gab2 is phosphorylated by ZAP-70 and negatively regulates T cell receptor signaling by recruitment of inhibitory molecules. J. Biol. Chem. 276, 45175\u201383 (2001).","journal-title":"J. Biol. Chem."},{"key":"57919_CR58","first-page":"138","volume":"1775","author":"AS Wilson","year":"2007","unstructured":"Wilson, A. S., Power, B. E. & Molloy, P. L. DNA hypomethylation and human diseases. Biochim. Biophys. Acta. 1775, 138\u201362 (2007).","journal-title":"Biochim. Biophys. Acta."},{"key":"57919_CR59","unstructured":"Jaffe, E. S., Harris, N. L., Stein, H. & Vardiman, J. W. Chronic lymphocytic leukaemia\/small lymphocytic lymphoma. In WHO Classification of Tumours of Haematopoietic and Lymphoid Tissues (eds. Muller-Hermelink, H. K., Montserrat, E., Catovsky, D. & Harris, N. L.) 127\u2013130 (IARC, 2001)."},{"key":"57919_CR60","unstructured":"Swerdlow, S. H. et al. Chronic lymphocytic leukaemia\/small lymphocytic lymphoma. In WHO Classification of Tumours of Haematopoietic and Lymphoid Tissues (eds. Muller-Hermelink, H.K. et al.) 180\u2013182 (IARC, 2008)."},{"key":"57919_CR61","doi-asserted-by":"publisher","first-page":"5446","DOI":"10.1182\/blood-2007-06-093906","volume":"111","author":"M Hallek","year":"2008","unstructured":"Hallek, M. et al. Guidelines for the diagnosis and treatment of chronic lymphocytic leukemia: a report from the International Workshop on Chronic Lymphocytic Leukemia updating the National Cancer Institute-Working Group 1996 guidelines. Blood. 111, 5446\u201356 (2008).","journal-title":"Blood."},{"key":"57919_CR62","doi-asserted-by":"publisher","first-page":"2114","DOI":"10.1093\/bioinformatics\/btu170","volume":"30","author":"AM Bolger","year":"2014","unstructured":"Bolger, A. M., Lohse, M. & Usadel, B. Trimmomatic: a flexible trimmer for Illumina sequence data. Bioinformatics. 30, 2114\u201320 (2014).","journal-title":"Bioinformatics."},{"key":"57919_CR63","doi-asserted-by":"publisher","DOI":"10.1186\/gb-2009-10-3-r25","volume":"10","author":"B Langmead","year":"2009","unstructured":"Langmead, B., Trapnell, C., Pop, M. & Salzberg, S. L. Ultrafast and memory-efficient alignment of short DNA sequences to the human genome. Genome Biol. 10, R25 (2009).","journal-title":"Genome Biol."},{"key":"57919_CR64","doi-asserted-by":"publisher","first-page":"284","DOI":"10.1093\/bioinformatics\/btt650","volume":"30","author":"M Lienhard","year":"2014","unstructured":"Lienhard, M., Grimm, C., Morkel, M., Herwig, R. & Chavez, L. MEDIPS: genome-wide differential coverage analysis of sequencing data derived from DNA enrichment experiments. Bioinformatics. 30, 284\u20136 (2014).","journal-title":"Bioinformatics."},{"key":"57919_CR65","doi-asserted-by":"publisher","first-page":"139","DOI":"10.1093\/bioinformatics\/btp616","volume":"26","author":"MD Robinson","year":"2010","unstructured":"Robinson, M. D., McCarthy, D. J. & Smyth, G. K. edgeR: a Bioconductor package for differential expression analysis of digital gene expression data. Bioinformatics. 26, 139\u201340 (2010).","journal-title":"Bioinformatics."},{"key":"57919_CR66","doi-asserted-by":"publisher","DOI":"10.1186\/1756-0500-3-277","volume":"3","author":"N Servant","year":"2010","unstructured":"Servant, N. et al. EMA - A R package for Easy Microarray data analysis. BMC Res. Notes. 3, 277 (2010).","journal-title":"BMC Res. Notes."},{"key":"57919_CR67","doi-asserted-by":"publisher","first-page":"2382","DOI":"10.1093\/bioinformatics\/btv145","volume":"31","author":"G Yu","year":"2015","unstructured":"Yu, G., Wang, L. G. & He, Q. Y. ChIPseeker: an R\/Bioconductor package for ChIP peak annotation, comparison and visualization. Bioinformatics. 31, 2382\u20133 (2015).","journal-title":"Bioinformatics."},{"key":"57919_CR68","doi-asserted-by":"publisher","first-page":"284","DOI":"10.1089\/omi.2011.0118","volume":"16","author":"G Yu","year":"2012","unstructured":"Yu, G., Wang, L. G., Han, Y. & He, Q. Y. clusterProfiler: an R package for comparing biological themes among gene clusters. OMICS. 16, 284\u20137 (2012).","journal-title":"OMICS."},{"key":"57919_CR69","doi-asserted-by":"publisher","first-page":"D590","DOI":"10.1093\/nar\/gky962","volume":"47","author":"M Kanehisa","year":"2019","unstructured":"Kanehisa, M., Sato, Y., Furumichi, M., Morishima, K. & Tanabe, M. New approach for understanding genome variations in KEGG. Nucleic Acids Res. 47, D590\u2013D595 (2019).","journal-title":"Nucleic Acids Res."},{"key":"57919_CR70","doi-asserted-by":"publisher","first-page":"W501","DOI":"10.1093\/nar\/gkx372","volume":"45","author":"W Luo","year":"2017","unstructured":"Luo, W., Pant, G., Bhavnasi, Y. K., Blanchard, S. G. Jr. & Brouwer, C. Pathview Web: user friendly pathway visualization and data integration. Nucleic Acids Res. 45, W501\u2013W508 (2017).","journal-title":"Nucleic Acids Res."},{"key":"57919_CR71","doi-asserted-by":"publisher","first-page":"D833","DOI":"10.1093\/nar\/gkw943","volume":"45","author":"J Pi\u00f1ero","year":"2017","unstructured":"Pi\u00f1ero, J. et al. DisGeNET: a comprehensive platform integrating information on human disease-associated genes and variants. Nucleic Acids Res. 45, D833\u2013D839 (2017).","journal-title":"Nucleic Acids Res."},{"key":"57919_CR72","doi-asserted-by":"publisher","first-page":"2498","DOI":"10.1101\/gr.1239303","volume":"13","author":"P Shannon","year":"2003","unstructured":"Shannon, P. et al. Cytoscape: a software environment for integrated models of biomolecular interaction networks. Genome Res. 13, 2498\u2013504 (2003).","journal-title":"Genome Res."},{"key":"57919_CR73","doi-asserted-by":"publisher","DOI":"10.1186\/1471-2105-11-91","volume":"11","author":"A Martin","year":"2010","unstructured":"Martin, A. et al. BisoGenet: a new tool for gene network building, visualization and analysis. BMC Bioinformatics. 11, 91 (2010).","journal-title":"BMC Bioinformatics."},{"key":"57919_CR74","doi-asserted-by":"crossref","unstructured":"Wu, G., Dawson, E., Duong, A., Haw, R. & Stein, L. ReactomeFIViz: a Cytoscape app for pathway and network-based data analysis. Version 2, F1000Res (2014).","DOI":"10.12688\/f1000research.4431.2"},{"key":"57919_CR75","doi-asserted-by":"publisher","first-page":"670","DOI":"10.1038\/nprot.2012.004","volume":"7","author":"NT Doncheva","year":"2012","unstructured":"Doncheva, N. T., Assenov, Y., Domingues, F. S. & Albrecht, M. Topological analysis and interactive visualization of biological networks and protein structures. Nat. Protoc. 7, 670\u201385 (2012).","journal-title":"Nat. Protoc."}],"container-title":["Scientific Reports"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/www.nature.com\/articles\/s41598-020-57919-6.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/www.nature.com\/articles\/s41598-020-57919-6","content-type":"text\/html","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/www.nature.com\/articles\/s41598-020-57919-6.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2022,12,6]],"date-time":"2022-12-06T06:13:49Z","timestamp":1670307229000},"score":1,"resource":{"primary":{"URL":"https:\/\/www.nature.com\/articles\/s41598-020-57919-6"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2020,1,23]]},"references-count":75,"journal-issue":{"issue":"1","published-online":{"date-parts":[[2020,12]]}},"alternative-id":["57919"],"URL":"https:\/\/doi.org\/10.1038\/s41598-020-57919-6","relation":{},"ISSN":["2045-2322"],"issn-type":[{"value":"2045-2322","type":"electronic"}],"subject":[],"published":{"date-parts":[[2020,1,23]]},"assertion":[{"value":"26 August 2019","order":1,"name":"received","label":"Received","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"6 January 2020","order":2,"name":"accepted","label":"Accepted","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"23 January 2020","order":3,"name":"first_online","label":"First Online","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"The authors declare no competing interests.","order":1,"name":"Ethics","group":{"name":"EthicsHeading","label":"Competing interests"}}],"article-number":"1085"}}